Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:BEKE
NYSE:BEKEReal Estate

A Look At KE Holdings (NYSE:BEKE) Valuation After Its AI Focused Growth Strategy Update

KE Holdings (BEKE) shares moved after the company used its fourth quarter results on March 16 to outline an efficiency focused growth plan centered on systematic service upgrades and broader use of AI technology. See our latest analysis for KE Holdings. At a latest share price of US$15.63, KE Holdings has seen a 2.9% 1 day share price return and 5.3% 7 day share price return, but this follows a 30 day share price return of 6.0% and a 1 year total shareholder return of 13.5% loss. This...
ENXTAM:LIGHT
ENXTAM:LIGHTElectrical

Assessing Signify (ENXTAM:LIGHT) Valuation After Sustainability Push And Horticulture Lighting Award

Recent sustainability and product milestones at Signify (ENXTAM:LIGHT), including its Brighter Lives, Better World 2030 programme and an award winning horticulture lighting system, have put the company’s environmental commitments and technology capabilities in sharper focus for investors. See our latest analysis for Signify. The recent sustainability push, horticulture award and US agency realignment come as the share price sits at €19.35, with a 3.48% 1 month share price return but a 10.50%...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

A Look At Huntington Bancshares (HBAN) Valuation After New University Of Michigan Banking Partnership

Huntington Bancshares (HBAN) is in focus after Huntington National Bank was named the Official Consumer Bank of the University of Michigan, giving the lender exclusive access to a large campus community. See our latest analysis for Huntington Bancshares. The latest partnership news comes as the share price sits at US$16.35, with a 7 day share price return of 3.55% and a 90 day share price return decline of 10.36%, while the 1 year total shareholder return of 31.72% shows stronger longer term...
NasdaqGM:MDB
NasdaqGM:MDBIT

Could Nutanix Automation Deal Reveal a New Edge in MongoDB’s (MDB) Enterprise Data Platform Strategy?

Nutanix recently announced a certified integration between its Nutanix Database Service and MongoDB Ops Manager, aiming to automate provisioning, monitoring, and backup workflows for large-scale, business-critical MongoDB deployments. This collaboration strengthens MongoDB’s position as a unified data platform for operational workloads, search, and AI-powered retrieval by embedding its tools more deeply into enterprise infrastructure automation. We’ll now assess how the Nutanix–MongoDB...
NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

SEALSQ (LAES) Is Down 14.7% After Revenue Triples And Post-Quantum Milestones Advance - What's Changed

SEALSQ Corp. recently reported preliminary unaudited first-quarter 2026 revenue of about US$4.1 million, more than tripling its first-quarter 2025 sales of US$1.3 million, alongside further progress in post-quantum hardware and security certification programs. This combination of rapid sales acceleration and concrete milestones toward Common Criteria and FIPS certifications highlights SEALSQ’s growing role in securing next-generation IoT and critical infrastructure devices. Next, we’ll...
NYSE:DOC
NYSE:DOCHealth Care REITs

Is It Time To Reconsider Healthpeak Properties (DOC) After Recent Share Price Recovery?

Wondering whether Healthpeak Properties at around US$16.68 is offering good value or not? This article breaks down what the current price might be implying about the stock. The share price is up 1.8% over the last 7 days and 3.0% year to date, even though the 1 year return sits at a 4.1% decline and the 5 year return at a 32.7% decline. Recent coverage has focused on how Healthpeak fits into the broader Health Care REITs space and how investors are weighing income potential against interest...
NasdaqGS:ONB
NasdaqGS:ONBBanks

A Look At Old National Bancorp (ONB) Valuation As Analyst Optimism Builds

Analyst optimism puts fresh focus on Old National Bancorp (ONB) Recent research updates from Barclays, Citigroup, Truist Securities, RBC Capital, and Stephens & Co. have put Old National Bancorp (ONB) back on investor radars, as consistent analyst optimism shapes current sentiment around the regional bank. See our latest analysis for Old National Bancorp. Old National Bancorp’s recent 3.3% 1 day share price return and 4.1% 7 day share price return to US$23.25 come after a solid 21.0% 1 year...
NYSE:ABBV
NYSE:ABBVBiotechs

Is AbbVie (ABBV) Still Attractive After Recent Pullback And Mixed Valuation Signals

If you are wondering whether AbbVie at around US$211.59 is still offering value or if most of the upside is already priced in, this article breaks down what the numbers are saying about the stock. The share price sits near US$211.59 after a 1.6% decline over the last week and a 7.0% pullback over the past month, while the 1 year return is 21.6% and the 5 year return is 139.0%. Recent headlines have focused on AbbVie as a major player in large cap pharmaceuticals, with attention on its...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron Expands AI Memory Story With SiMa.ai Deal And Taiwan Buildout

Micron Technology (NasdaqGS:MU) has invested in SiMa.ai to integrate its LPDDR5X memory into SiMa's Modalix MLSoC platform for physical AI systems at the edge. The partnership targets real world use cases such as robotics, autonomous systems, and industrial automation. Micron is expanding its Taichung, Taiwan mega campus, including acquiring Powerchip's P5 site for retrofit and future HBM and DRAM production. The company also signals further expansion at Tongluo to support next generation...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Is It Too Late To Consider Pebblebrook Hotel Trust (PEB) After Its 43% One-Year Rally?

Wondering whether Pebblebrook Hotel Trust at around US$13.38 is still offering value after its recent run, or if most of the opportunity is already priced in. The stock has returned 5.7% over the last 7 days, 7.0% over the last 30 days, 15.8% year to date, and 43.1% over the last year, while 3 year and 5 year returns stand at a 5.0% decline and a 44.5% decline. Recent coverage has focused on Pebblebrook as a hotel focused REIT, with attention on how travel activity, room demand and real...
NYSE:TGT
NYSE:TGTConsumer Retailing

Is Target (TGT) Offering Value After Its Recent Share Price Rebound?

If you are wondering whether Target's current share price still offers value, it helps to step back and look at what the recent numbers are really saying about the stock. Target shares most recently closed at US$123.12, with returns of 2.2% over 7 days, 2.5% over 30 days, 22.5% year to date and 31.8% over 1 year, while the 3 year and 5 year returns sit at 16.1% and 30.8% declines. These mixed return figures place more attention on broader company developments and how investors are...
ASX:PWH
ASX:PWHAuto Components

ASX Growth Stocks Backed By Insiders

The Australian stock market is experiencing a mixed phase, with recent gains followed by profit-taking as geopolitical tensions create uncertainty. Amidst this backdrop, growth companies with high insider ownership can be attractive due to the confidence insiders demonstrate in their businesses.
ASX:SDR
ASX:SDRSoftware

ASX Stocks Trading Below Estimated Intrinsic Value In April 2026

As the Australian stock market experiences a cautious start amid geopolitical tensions and recent profit-taking, investors are keenly observing opportunities that might arise from these fluctuations. In this environment, identifying stocks trading below their estimated intrinsic value can offer potential for growth, especially as global markets show signs of optimism.
ASX:SYL
ASX:SYLConstruction

Discovering 3 Hidden Australian Stocks with Strong Potential

The Australian market has recently experienced a mix of volatility and optimism, with the ASX 200 seeing significant gains followed by a softer opening, amid geopolitical tensions and fluctuating commodity prices. In this dynamic environment, identifying hidden gems in the small-cap sector requires focusing on companies that demonstrate resilience and potential for growth despite broader market uncertainties.
ASX:PRG
ASX:PRGMetals and Mining

ASX Penny Stocks To Watch In April 2026

Australian shares are experiencing a cautious start to the day amid geopolitical tensions, despite recent significant gains in global markets. In such a climate, investors often seek opportunities that balance risk and reward, making penny stocks an intriguing option. While the term 'penny stocks' may seem outdated, these smaller or newer companies can still offer growth potential when supported by strong financial health.
ASX:STO
ASX:STOOil and Gas

Does Alaska Quokka Light Oil Find Versus Softer Prices Shift Santos’ Macro Leverage (ASX:STO)?

Santos recently reported that its Quokka-1 appraisal well on Alaska’s North Slope encountered high‑quality reservoir sands and confirmed light oil, while broader market sentiment shifted as oil prices fell following reduced geopolitical tensions in the Middle East. This combination highlights how promising Alaskan resource additions can be outweighed in the near term by macro-driven shifts in global oil pricing. We’ll now examine how the confirmed Alaskan light oil discovery shapes Santos’...
TSX:ELE
TSX:ELEMetals and Mining

Elemental Royalty (TSX:ELE) Valuation Check After S&P/TSX Venture Index Removal

Index removal puts Elemental Royalty (TSX:ELE) under the spotlight Elemental Royalty (TSX:ELE) has been dropped from the S&P/TSX Venture Composite Index. This index change can prompt rebalancing by index-linked funds and shift how larger institutions are positioned in the stock. See our latest analysis for Elemental Royalty. The index removal comes after a mixed stretch for the stock, with a 1-day share price return of 5.08% following a 30-day share price decline of 14.03%. However, a year to...
ENXTPA:ANTIN
ENXTPA:ANTINCapital Markets

A Look At Antin Infrastructure Partners (ENXTPA:ANTIN) Valuation After New U.S. Distributed Energy Partnership

Sapphire Gas Solutions’ new partnership with Antin Infrastructure Partners SAS (ENXTPA:ANTIN) places Antin at the center of the U.S. push for distributed, on-site natural gas infrastructure serving energy-intensive users. See our latest analysis for Antin Infrastructure Partners SAS. Antin’s latest partnership comes as the share price trades at €10.36, with a 1 month share price return of 10.8% after a weaker 90 day share price return of a 7.83% decline. The 1 year total shareholder return of...
NYSE:APH
NYSE:APHElectronic

Amphenol (APH) Is Up 6.0% After AI Datacenter Demand Lifts Nvidia Connector Sales

In recent months, Amphenol’s IT datacom segment outperformed as hyperscaler AI data center capital spending increased and demand for its high-speed interconnect solutions, including those supplied to Nvidia, remained strong. At the same time, acquisitions such as CommScope’s CCS business have expanded Amphenol’s reach across industrial, communications, defense, and aerospace markets while introducing fresh tariff and growth-related risks that investors need to weigh carefully. Next, we’ll...
NYSE:CMC
NYSE:CMCMetals and Mining

Is Profit Turnaround And Aggressive Buyback Altering The Investment Case For Commercial Metals (CMC)?

In March 2026, Commercial Metals Company reported past second-quarter sales of US$2,132.02 million and net income of US$93.03 million, alongside six-month sales of US$4,252.33 million and net income of US$270.31 million, marking a clear turnaround from the prior year’s loss. Over the same period, the company also advanced its capital return efforts by completing a share repurchase of 15,131,239 shares for US$702.21 million, shrinking its share count and signaling confidence in its financial...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia’s L606 Puts New Focus On Pulmonary Hypertension Growth Story

Liquidia (NasdaqCM:LQDA) is drawing attention after its investigational drug L606 was highlighted as a potential transformative therapy in the interstitial lung disease market. The candidate targets patients facing pulmonary hypertension and related conditions, positioning L606 as a possible new standard of care if clinical development progresses successfully. For investors tracking biopharma, Liquidia focuses on therapies for pulmonary hypertension and related respiratory conditions, an...
NYSE:CAVA
NYSE:CAVAHospitality

Is It Too Late To Consider Cava Group (CAVA) After Its Recent Share Price Rebound?

Wondering if CAVA Group at around US$86 is priced for growth or already ahead of itself? This article walks through what the current share price might imply about value. The stock has been active recently, with a 7.6% return over the last 7 days, 5.4% over 30 days, a 42.4% return year to date, and a 6.2% decline over the past year. Recent coverage has focused on CAVA Group as a newly listed fast casual restaurant brand. Attention has centered on how quickly the market has formed an opinion...
NYSE:BLDR
NYSE:BLDRBuilding

Is It Time To Revisit Builders FirstSource (BLDR) After A 33% One-Year Share Price Decline

If you are wondering whether Builders FirstSource at around US$83.09 is a bargain or a value trap, you are in the right place for a clear look at what the current price might imply. The stock has recently seen a 2.6% move over the last 7 days, against a 12.5% decline over 30 days and a 33.4% decline over the past year, so recent returns may be raising questions about future upside or risk. Recent coverage has focused on how building products suppliers like Builders FirstSource are positioned...
NYSE:SYF
NYSE:SYFConsumer Finance

Is Synchrony (SYF) Quietly Redefining Health Financing With Its Walmart.com CareCredit Expansion?

In early April 2026, Synchrony announced that CareCredit cardholders can now use their health and wellness credit card for eligible purchases on Walmart.com, adding new categories such as medical supplies, fitness equipment, sleep products, and pet care to its already wide acceptance in Walmart, Sam’s Club, and more than 290,000 health-related locations. By pairing this expanded CareCredit access with fresh financial literacy grants for K–12 teachers and schools, Synchrony is broadening both...